Effect of 2-amino-2-[2-(4-octylphenyl)ethyl] propane-1,3-diol hydrochloride (FTY 720) on immune liver injury in mice

World Journal of Gastroenterology

Volumn 11, Issue 4, 2005, Pages 573-576

  He, Jing Hua ^a   Zhang, Hui Na ^a   Lin, Zhi Bin ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

Apoptosis; Cell proliferation; FTY 720; Immune liver injury

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CONCANAVALIN A; EOSIN; FINGOLIMOD; GAMMA INTERFERON; HEMATOXYLIN; INTERLEUKIN 4;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE MODEL; DOSE RESPONSE; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HISTOPATHOLOGY; IMMUNOPATHOLOGY; LIVER CELL DAMAGE; LIVER INJURY; LIVER PROTECTION; MALE; MOUSE; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; SPLEEN CELL; SUPERNATANT; TREATMENT OUTCOME;

EID: 13244253993     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v11.i4.573     Document Type: Article

References (21)

1. Luo KX. Hepatitis B Basic Biology and Clinical Science. 2nd ed, Beijing: People's Health Publishing House 2001: 381-444
2. Zhang XL, Quan QZ, Sun ZQ, Wang YJ, Jiang XL, Wang D, Li WB. Protective effects of cyclosporine A on T-cell dependent ConA-induced liver injury in kunming mice. World J Gastroenterol 2001; 7: 569-571
3. Kaibori M, Inoue T, Tu W, Oda M, Kwon AH, Kamiyama Y, Okumura T. FK506, but not cyclosporin A, prevents mitochondrial dysfunction during hypoxia in rat hepatocytes. Life Sci 2001; 69 17-26
4. Hershkoviz R, Bruck R, Aeed H, Shirin H, Halpern Z. Treatment of concanavalin A-induced hepatitis in mice with low molecular weight heparin. J Hepatol 1999; 31: 834-840
5. Adachi K, Kohara T, Nakano N, Arita M, Chiba K, Mashin T, Sassaki S, Fujita T. Design Synthesis and structure-activity relationship of 2-substituted-2-amino-1, 2-propanediols: discovery of a novel immunosuppressant, FTY720. Bioorg Med Chem Lett 1995; 5 853-856
6. Hwang MW, Matsumori A, Furukawa Y, Ono K, Okada M, Iwasaki A, Hara M, Sasayama S. FTY720, a new immunosuppressant, promotes long-term graft survival and inhibits the progression of graft coronary artery disease in a murine model of cardiac transplantation. Circulation 1999; 100: 1322-1329
7. Hozumi Y, Kobayashi E, Miyata M, Fujimura A. Immunotherapy for experimental rat autoimmune thyroiditis using a novel immunosuppressant, FTY720. Life Sci 1999; 65: 1739-1745
8. Yan H, Suzuki K, Li XK, Amemiya H, Suzuki S, Hiromitsu K. Immunosuppressive effect of FTY 720 on autoimmune diabetes models. Transplant Proc 1998; 30: 3436-3437
9. Permpongkosol S, Wang JD, Takahara S, Matsumiya K, Nonomura N, Nishimura K, Tsujimura A, Kongkanand A, Okuyama A. Anticarcinogenic effect of FTY720 in human prostate carcinoma DU145 cells: modulation of mitogenic signaling, FAK, cell-cycle entry and apoptosis. Int J Cancer 2002; 98: 167-172
10. Anselmo D, Amersi FF, Shen XD, Gao F, Katori M, Ke B, Lassman C, Coito AJ, Brinkmann V, Busuttil RW, Kupiec-Weglinski JW, Farmer DG. FTY720: a novel approach to the treatment of hepatic ischemia-reperfusion injury. Transplant Proc 2002; 34: 1467-1468
11. 2 in primary cultured rat hepatocytes. Prostaglandins 1993; 45: 459-474
12. Suzuki S, Li XK, Enosawa S, Shinomiya T. A new immunosuppressant, FTY720, induces bcl-2-associated apoptotic cell death in human lymphocytes. Immunology 1996; 89: 518-523
13. Nagahara Y, Enosawa S, Ikekita M, Suzuki S, Shinomiya T. Evidence that FTY720 induces T cell apoptosis in vivo. Immunopharmacology 2000; 48: 75-85
14. Fujino M, Li XK, Guo L, Kitazawa Y, Funeshima N, Fukuda S, Kimura H, Miyashita T, Okuyama T, Amano T, Suzuki S. T-cell apoptosis triggered by FTY720 via mitochondrial pathway. Transplant Proc 2001; 33: 3084-3085
15. Ramadori G, Armbrust T. Cytokines in the liver. Eur J Gastroenterol Hepatol 2001; 13: 777-784
16. Leist M, Wendel A. A novel mechanism of murine hepatocyte death inducible by concanavalin A. J Hepatol 1996; 25 948-959
17. Kimura K, Ando K, Ohnishi H, Ishikawa T, Kakumu S, Takemura M, Muto Y, Moriwaki H. Immunopathogenesis of hepatic fibrosis in chronic liver injury induced by repeatedly administered concanavalin A. Int Immunol 1999; 11: 1491-1500
18. Gantner F, Leist M, Lohse AW, Germann PG, Tiegs G. Concanavalin A-induced T-cell-mediated hepatic injury in mice: the role of tumor necrosis factor. Hepatology 1995; 21: 190-198
19. Batey R, Pang G, Russell A, Clancy R. IL-6, IFN-γ and TNF-α production by liver-associated T cell and acute liver injury in rats administered concanavalin A. Immunol Cell Biol 1998; 76: 542-548
20. Nishikage T, Seki S, Toyabe S, Abo T, Kagata Y, Iwai T, Hiraide H. Inhibition of concanavalin A-induced hepatic injury of mice by bacterial lipopolysaccharide via the induction of IL-6 and the subsequent reduction of IL-4: the cytokine milieu of concanavalin A hepatitis. J Hepatol 1999; 31: 18-26
21. Kato M, Ikeda N, Matsushita E, Kaneko S, Kobayashi K. Involvement of IL-10, an anti-inflammatory cytokine in murine liver injury induced by Concanavalin A. Hepatol Rese 2001; 20: 232-243